CAU
WST icon

Caxton Associates (UK)’s West Pharmaceutical WST Stock Holding History

Caxton Associates (UK)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$365K Buy
+1,457
New +$363K 0.01% 560
2025
Q3 		– Sell
-7,360
Closed -$1.61M – 954
2025
Q2 		$1.61M Buy
+7,360
New +$1.57M 0.04% 232

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caxton Associates (UK)'s WST Position: Q1 2026 in Review

Caxton Associates (UK) opened a new position in West Pharmaceutical (WST) in Q1 2026: 1,457 shares worth $365K. The stake represents 0.01% of the portfolio and ranks #560 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in WST as recently as Q2 2025.

Caxton Associates (UK) first reported a position in WST in Q2 2025 and has held it in 2 quarters since. The position peaked at $1.61M in Q2 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Caxton Associates (UK) held 1,457 shares of West Pharmaceutical worth $365K as of Q1 2026.
  • West Pharmaceutical was a new Caxton Associates (UK) position in Q1 2026.
  • West Pharmaceutical made up 0.01% of Caxton Associates (UK)'s portfolio in Q1 2026, its #560 holding.
  • Caxton Associates (UK) first reported a position in West Pharmaceutical in Q2 2025 and has held it in 2 quarters since.
  • Caxton Associates (UK)'s West Pharmaceutical position peaked at $1.61M in Q2 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.